What is TRIOMICS?
TRIOMICS is at the forefront of powering next-generation applications for healthcare data and systems, specifically aimed at advancing clinical research. By harnessing the growing maturity of US healthcare on the FHIR (Fast Healthcare Interoperability Resources) standard and addressing its current limitations, TRIOMICS empowers healthcare organizations at any phase of their FHIR adoption journey. The company's innovative approach facilitates seamless data exchange and utilization, crucial for accelerating research and improving patient outcomes.
How much funding has TRIOMICS raised?
TRIOMICS has raised a total of $37M across 2 funding rounds:
Series A
$15M
Series B
$22M
Series A (2024): $15M with participation from Lightspeed, General Catalyst, Y Combinator, and Nexus Venture Partners
Series B (2026): $22M led by Nexus Venture Partners, Lightspeed Venture Partners, Battery, and Y Combinator
Key Investors in TRIOMICS
Nexus Venture Partners
Nexus Venture Partners is a venture capital firm specializing in seed, startup, growth capital, and early-stage investments, founded in 2006 and based in California.
Lightspeed Venture Partners
Lightspeed Venture Partners is a global multistage venture capital firm investing in early and growth-stage technology companies across enterprise software, consumer, fintech, and infrastructure.
Battery
Battery Ventures is a global investment firm that partners with entrepreneurs and management teams to build and scale category-defining technology businesses, focusing on innovative companies across various stages of growth.
What's next for TRIOMICS?
With this substantial infusion of capital, TRIOMICS is poised for accelerated growth and market expansion. The strategic investment is expected to fuel further development of its platform, enhance its data interoperability solutions, and broaden its reach within the healthcare ecosystem. Future initiatives will likely focus on deepening partnerships with healthcare providers and research institutions, solidifying TRIOMICS' position as a leader in healthcare data modernization and clinical research enablement. The company's trajectory suggests a strong focus on leveraging FHIR standards to unlock new possibilities in data-driven healthcare.
See full TRIOMICS company page
